A B S T R A C T The effect of hypermagnesemia, produced by MgCla infusion, on the activity of parathyroid glands, as assessed by changes in levels of serum calcium (Sca) and in the fraction of filtered phosphate excreted (CP/Ccr), was studied in 11 intact and 4 thyroparathyroidectomized (T-PTX) dogs. To exclude the effect of diurnal variation in CP/Ccr on the results, studies were initiated in both morning and afternoon hours and each study with MgCL infusion was paired with a control experiment in the same dog not receiving MgCl2. During MgCL infusion, serum phosphorus rose progressively. Despite this rise, the levels of CP/Ccr fell in all experiments and were significantly different from values observed at the same time of the day in the paired control experiments. The concentrations of total Sca fell by 1.0-2.4 mg/100 ml with a proportional decrease in the levels of the diffusible and ionized fractions. The pattern of the fall in CP/Cc, during MgCl2 resembled that observed after CaClh infusion (seven dogs) and that which acutely followed thyroparathyroidectomy (seven dogs). When parathyroid extract was given to dogs receiving MgCla infusion both CP/CCr and Sc. rose, and MgClh infusion did not affect CP/Ccr and Sc. in T-PTX dogs. These results indicate that hypermagnesemia suppresses the activity of the parathyroid glands, probably, by inhibiting production and (or) release of the hormone, without interfering with end-organ response. An increase in serum magnesium of 1.7-2.0 mg/100 ml was capable of producing the suppressive effect. Evaluation of the effect This work was presented in part before the Western Section of the American Federation for Clinical Research, Carmel, Calif., 2 February 1968. Dr. Massry is an Established Investigator of the American Heart Association.
A B S T R A C T The effect of hypermagnesemia, produced by MgCla infusion, on the activity of parathyroid glands, as assessed by changes in levels of serum calcium (Sca) and in the fraction of filtered phosphate excreted (CP/Ccr), was studied in 11 intact and 4 thyroparathyroidectomized (T-PTX) dogs. To exclude the effect of diurnal variation in CP/Ccr on the results, studies were initiated in both morning and afternoon hours and each study with MgCL infusion was paired with a control experiment in the same dog not receiving MgCl2. During MgCL infusion, serum phosphorus rose progressively. Despite this rise, the levels of CP/Ccr fell in all experiments and were significantly different from values observed at the same time of the day in the paired control experiments. The concentrations of total Sca fell by 1.0-2.4 mg/100 ml with a proportional decrease in the levels of the diffusible and ionized fractions. The pattern of the fall in CP/Cc, during MgCl2 resembled that observed after CaClh infusion (seven dogs) and that which acutely followed thyroparathyroidectomy (seven dogs). When parathyroid extract was given to dogs receiving MgCla infusion both CP/CCr and Sc. rose, and MgClh infusion did not affect CP/Ccr and Sc. in T-PTX dogs. These results indicate that hypermagnesemia suppresses the activity of the parathyroid glands, probably, by inhibiting production and (or) release of the hormone, without interfering with end-organ response. An increase in serum magnesium of 1.7-2.0 mg/100 ml was capable of producing the suppressive effect. Evaluation of the effect INTRODUCTION Although it is well documented that the concentration of ionized calcium in the plasma is of primary importance in regulating parathyroid hormone secretion (1) (2) (3) , evidence exists suggesting that the level of blood magnesium may also play a role in the regulation of the activity of the parathyroid glands. In the rat, magnesium deficiency and hypomagnesemia may stimulate the parathyroid glands (4) (5) (6) . Gitelman, Kukolj, and Welt (7) reported data in nephrectomized rats compatible with the concept that hypermagnesemia may suppress the activity of the parathyroid glands in the rat; their studies, however, do not exclude the possibility that the hypocalcemic effect of magnesium injections could have been produced by mechanism(s) other than the inhibition of the parathyroid glands. In four experiments utilizing the in vivo perfusion of isolated parathyroid glands in goats and sheep with perfusate containing high concentration of magnesium, there was an inverse correlation between the level of parathyroid hormone in the affluent blood and the concentration of magnesium in the perfusate in three experiments; this correlation was highly significant in only one study (8) .
The relation between magnesium metabolism and the activity of parathyroid glands in the dog and man has not been delineated. Magnesium deficiency in the dog may be associated with normal or low levels of serum calcium (9) (10) (11) (12) ; the effect of acute hypermagnesemia on the activity of the parathyroid glands has not been studied in the species. In man, magnesium deficiency and hypomagnesemia may be accompanied by hypocalcemia (13) , which cannot be corrected by the administration of parathyroid extract, suggesting that the skeleton is rendered resistant to the action of parathormone. The repeated injections of magnesium salts (14) and oral magnesium loading (15) to humans were associated with a decrease in phosphate excretion; these results were not attributed to inhibition of parathyroid glands. Furthermore, the relative importance of simultaneous changes in the concentration of serum calcium and magnesium in the regulation of the activity of parathyroid glands is not known.
The present study was undertaken to evaluate the effect of acute hypermagnesemia on the activity of the parathyroid glands in the dog as assessed by changes in the concentration of serum calcium and in the fraction of filtered phosphate excreted. The influence of a simultaneous hypermagnesemia and hypocalcemia on the activity of these glands was also studied. Mg"|/kg per min from 3:00 p.m. to 6:00 p.m., and the experiments were then continued until 9:00 p.m. with only 0.45% saline infused.
METHODS
The effect of MgC12 was also evaluated in four T-PTX dogs. Thyroparathyroidectomy was performed under pentobarbital anesthesia 2-3 days before the first study. The complete removal of the parathyroid glands was confirmed by the appearance of hypocalcemia. The dogs received liberal amounts of calcium and phosphate in their diet, and they remained in good condition for at least 10 days. Both a control experiment and a study with the infusion of MgCl2 were carried out in each dog between 3:00 p.m. Blood and urine samples were analyzed for creatinine by the Jaffe reaction (16) and for phosphate by the method of Fiske and Subbarow (17), and calcium and magnesium were measured by the Perkin Elmer atomic absorption spectrophotometer, model 303. Diffusible calcium and magnesium and ionized calcium were measured in ultrafiltrates of serum prepared anaerobically in Lavietes chambers at room temperature (18) . The concentration of ionized calcium was measured by a micromodification of the method of Ettori and Scogan (19 The detailed protocols of an experiment with magnesium chloride infusion and its paired control study, both initiated during the morning hours, are presented in Table I , and representative protocols of similar studies began in the afternoon hours are shown in Table II serum concentration of total magnesium to levels of 8-11 mg/100 ml at the end of the experiment; since there was no significant change in the per cent diffusibility of serum magnesium, the increments in levels of dif fusible magnesium were proportional to changes of the total concentration of this ion. The hypermagnesemia was associated with a decrease in the concentration of total serum calcium of 1.0-2.4 mg/100 ml and a proportional fall in levels of the diffusible and ionized fractions of calcium. The decrement in the concentration of serum calcium was gradual, and the mean value for the entire group was significantly lower than the control level by the 5th hr of MgCl2 infusion (P = 0.02).
The serum concentration of inorganic phosphorus increased from 4.0 ±0.37 to 6.8 ±0.58 mg/100 ml (mean +SE) in the morning studies and from 4.9 ±0.20 to 8.1 ±0.91 mg/100 ml in the afternoon studies. Despite this increase in the level of serum phosphorus and the subsequent rise in filtered phosphate, the fraction of filtered phosphate excreted fell markedly and remained low as long as the magnesium infusion was continued. In studies initiated in the morning hours, the fall in CP/CC' during the first 2 hr of the MgCls coincided with the decrease in CP/Cc7 observed as part of the normal diurnal variation; therefore, it was not possible to assess the level of serum magnesium at which a change in CP/Cc, had first occurred. However, the studies started in the afternoon hours would allow such an evaluation. When the concentration of serum magnesium increased by 2.0-3.0 ml to levels of 3.5-4.5 mg/100 ml, there was a significant fall in CP-Cow (P < 0.01).
When parathyroid extract was administered to four animals receiving MgCls infusion, the concentration of serum calcium rose by 1.0-2.0 mg/100 ml (from 8.9 ±0.16 to 10.4 ±0.44 mg/100 ml). The levels of serum phosphorus increased from 4.1 ±0.42 to 6.9 ±0.30 mg/ 100 ml, and the magnitude of this increase was similar to that observed in experiments with only MgCL infused. Fractional Representative experiments in a T-PTX dog, with and without MgCla infusion, are shown in Table IV . The summary of changes in the concentrations of serum calcium and in CP/Ccr in all such studies is presented in Fig. 5 . The infusion of MgCla caused a significant rise in the concentration of serum phosphorus (from 5.5 +0.37 to 7.4 ±0.21 mg/100 ml) and a slight decrease in the levels of serum calcium. However, in these T-PTX animals, the levels of serum calcium and the changes in CPICa, were not different during MgCl2 infusion from observations made in control studies carried out without MgCl2 infusions in the same dogs.
The infusion of 40 yig Mg^/kg per min caused a smaller rise in the concentration of serum magnesium to 4.27 ±0.07 mg/100 ml after 3 hr of the infusion; by this time, serum calcium had fallen from 10.8 +0.14 to 9.8 ±0.26 mg/100 ml and CP/CCr had decreased markedly (Table V) . This fall in CP/CCr was significant (P < 0.05) after serum magnesium had increased by 1.7-2.0 mg/100 ml to a mean level of 3.28 +0.09 mg/ 100 ml. Following the discontinuation of MgCl2 infusion, there was a gradual fall in serum magnesium, serum calcium remained low, but CP/Cc, rose abruptly and often reached values greater than those seen before the infusion of MgCl2 (Table V) . A summary of four such experiments is presented in Fig. 6 . These studies demonstrate that CP/Cc, may increase in the presence of relative hypocalcemia despite the same degree of hypermagnesemia which otherwise causes CP/Cc, to fall.
Detailed protocols of an acute experiment during T-PTX and of that with the infusion of CaCl2 are presented in Tables VI and VII, respectively. The removal of the parathyroid glands was followed by a fall in the concentration of serum calcium by 1.0-2.0 mg/100 ml and by a marked decrease in CP/Ccr; the decrease in serum calcium level was significant (P < 0.05) by 2-3 hr after the removal of the parathyroid glands. The infusion of CaCI2 with the subsequent hypercalcemia was also followed by marked fall in CP/Ccr. The pattern and the magnitude of changes in CP/Ccr following either thyroparathyroidectomy or calcium infusion closely resembled those observed during the infusion of MgCl2 (Fig. 7) . DISCUSSION Although certain data are available suggesting that hypermagnesemia may suppress the activity of the parathyroid glands in vivo, such an effect has not been established with certainty. Gitelman, Kukolj, and Welt (7) showed that the injection of magnesium chloride to nephrectomized rats resulted in a small but significant decrease in the serum concentration of ionized calcium when compared with nephrectomized rats receiving only saline; the injection of magnesium chloride did not affect the level of ionized calcium in the blood when given to hypocalcemic parathyroidectomized and nephrectomized rats. These data are consistent with the hypothesis that hypermagnesemia may suppress the activity of the parathyroid glands but are not conclusive. The possibility that hypermagnesemia may interfere with the action of parathyroid hormone on bone was not excluded. Buckle, Care, Cooper, and Gitelman (8) performed in vivo perfusion of isolated parathyroid glands of one sheep and three goats with a blood perfusate containing magnesium in a concentration of 3.0-5.7 mg/100 ml. A decrease in the level of parathyroid hormone (PTH) in the effluent blood occurred. However, only in two goats did the change in PTH concentration exceed 1 SD (1.6 ng PTH/ml) for their immunoassay for measuring parathyroid hormone; furthermore, in one of these goats, the correlation between the level of parathyroid in the effluent blood and the magnesium concentration in the perfusate was not statistically significant. The results of the present study demonstrate that acute hypermagnesemia is associated with a significant decrease in the concentration of both total and ionized serum calcium, a rise in the level of blood inorganic phosphorus, and a marked fall in the fraction of filtered phosphate excreted. Theoretically, several mechanisms could be responsible for these changes. Magnesium infusion is associated with an increase in urinary calcium excretion (20) (21) (22) , and such losses might conceivably cause a fall in serum calcium levels. Total urinary calcium excretion, which was measured in six dogs, varied from 25 to 90 mg over the entire 6 hr period of MgCl. infusion. This amount of calcium is less than the theoretical loss necessary to cause the observed decrease in serum calcium levels, calculated from the assumption that calcium is distributed in extracellular fluid; since this-is a gross underestimate of the distribution of miscible calcium (23) , it is apparent that the fall in the levels of serum calcium cannot be explained by the urinary losses of this ion.
Stimulation of secretion of calcitonin can produce a fall in serum calcium (24) , and studies of Radde, Witterman, and Pensuwan (25) suggest that the early fall in levels of serum calcium caused by MgCL in the rat could be due to ever, perfusion of the thyroid glands of goats with blood containing a high concentration of magnesium failed to augment the secretion of calcitonin (26) . In addition, studies reported by Kleeman, Bernstein, and Chapman suggest that the homeostatic regulation of the levels of serum calcium in the dog is not affected by removal of the thyroid glands (27) . Following the administration of calcitonin, a decrease in serum calcium level occurs much more rapidly than was observed in the present study during the infusion of MgCl2; furthermore, calcitonin does not cause a decrease in urinary excretion of phosphate (26) . Although the present study does not exclude the possibility that infusion of MgCh may stimulate secretion of calcitonin in the dog, it is unlikely that such an event could be responsible for the present results.
The fall in fractional excretion of phosphate observed during MgCL infusion occurred at a time of the day when phosphate excretion is normally stable or rising.
A decrease in Cp/Cor could either be due to a reduction in filtered phosphate or to enhanced tubular reabsorption of phosphate. During MgCl2 infusion, glomerular filtration rate remained stable and the levels of serum phosphate increased; hence, filtered load of phosphate was elevated at a time when urinary excretion was falling, indicating an increase in the tubular reabsorption of phosphate.
Several features of the present study favor the conclusion that the infusion of MgClh produces its effect on serum calcium and phosphate excretion through inhibition of the activity of the parathyroid glands. The effects of acute hypermagnesemia on the concentration of serum calcium and on phosphate excretion were similar to those observed after parathyroidectomy; and the changes in urinary phosphate which occurred with hypercalcemia, which is known to inhibit activity of the parathyroid glands (1) (2) (3) , closely resembled those noted with hypermagnesemia. Furthermore, the elevation in serum calcium and the marked increase in fractional phosphate excretion which followed the administration of parathyroid extract to hypermagnesemic dogs indicate that hypermagnesemia, per se, does not interfere with the action of parathyroid hormone on its target organs, e.g., the skeleton and kidneys. Finally, hypermagnesemia failed to produce similar changes in serum calcium levels and phosphate excretion in thyroparathyroidectomized animals; this provides evidence that these effects of hypermagnesemia are mediated through the parathyroid glands and that hypermagnesemia, per se, does not significantly influence either the movement of calcium from bone or the excretion of phosphate by the kidneys. The mechanisms through which a rise in the concentration of magnesium in the blood may inhibit the activity of the parathyroid glands are not delineated in the present study; hypermagnesemia may inhibit the formation and (or) release of parathyroid hormone.
The rise in the concentration of serum phosphorus during hypermagnesemia is probably unrelated to the inhibition of the parathyroid glands or to the decrease in the urinary excretion of phosphate, since hyperphosphatemia occurred during hypermagnesemia, both in intact dogs receiving PTE and in the T-PTX animals. An increase in the level of serum phosphorus occurs The changes in mean serum calcium and in the fraction of filtered phosphate excreted (CP/Ccr) with calcium infusion (seven dogs) and following thyroparathyroidectomy, T-PTX (seven dogs). The changes in CP/Ccr are expressed as in Fig. 1 . The horizontal brackets encompass the period of time during which either calcium was infused or the parathyroid glands were surgically removed.
The results of the present study also permit an evaluation of the magnitude of increment in the concentration of serum magnesium which is required to inhibit the activity of the parathyroid glands. Data from the afternoon experiments, in which 100 Ag Mg++/kg per min was given, suggest that the activity of the parathyroid glands had already been suppressed as the concentration of serum magnesium increased by 2.0-3.5 mg/100 ml to levels of 3.5-5.0 mg/100 ml. Since the rate of rise in the level of serum magnesium was rapid in these experiments, it is possible that even a smaller increment in the concentration of serum magnesium may suppress the parathyroid glands. The results from the experiments in which a smaller amount of magnesium was infused (40 Ag/kg per min), indeed demonstrate that a significant fall in CP/Ccr became evident with a rise in the level of serum magnesium of only 1.7-2.0 mg/100 ml and at a serum concentration of 3.1-3.5 mg/ 100 ml. Although alterations in CP/Ccr may be a sensitive index of changes in the function of the parathyroid glands, the measurement of the levels of the parathyroid hormone in the blood will permit a more precise evaluation of the minimal increment in the level of serum magnesium which is necessary to suppress the activity of the glands. Increments in the concentration of serum magnesium of 1.7-2.0 mg/100 ml may be encountered in man under certain physiological and pathological states (e.g. following ingestion of oral magnesium salts and in uremia); therefore, it is possible that the relation between the levels of serum magnesium and activity of the parathyroid glands has physiological significance.
McIntyre, Boss, and Throughton (29) suggested that an interrelationship between magnesium and parathyroid hormone is important in the regulation of serum magnesium level. The ability of the kidneys to alter urinary excretion of magnesium with changes in the concentration of magnesium in blood is probably one of the major factors controlling the serum level of this ion (30) , and evidence has accumulated suggesting that parathyroid hormone causes enhanced renal tubular reabsorption of magnesium (22, 29) . With hypermagnesemia and consequent inhibition of the parathyroid glands, tubular reabsorption of magnesium may fall with enhanced urinary excretion; hence, serum magnesium level would return toward normal.
In the present study, a small decrease in the level of serum calcium was associated with an increase in fractional phosphate excretion and, presumably, increased parathyroid activity, despite the presence of hypermagnesemia which was initially sufficient to decrease CP/Cc7. These observations suggest that a decrease in the levels of serum calcium is more potent than a rise in the level of magnesium in the regulation of parathyroid activity.
